2 recruiting, 2 terminated, 1 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Recruiting 2, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Susan Chang: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma Hyperpolarized Pyruvate (13C), Magnetic Resonance Spectroscopic Imaging (MRSI) - Glioblastoma, Recurrent Glioblastoma | Phase 1 | Terminated | Susan Chang | 17 | 2019-11-19 | 2026-10-27 |
| 68Ga-citrate PET/MR Imaging for Glioma 68Ga-citrate PET/MR - Glioma | Terminated | Susan Chang | 2 | 2019-02-26 | 2020-05-01 | |
| Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance Imaging, Magnetic Resonance Spectroscopic Imaging - Recurrent World Health Organization (WHO) Grade II Glioma, Recurrent WHO Grade III Glioma | Phase 1 | Recruiting | Susan Chang | 300 | 2017-01-11 | 2026-04-29 |
| Hyperpolarized Imaging in Diagnosing Participants With Glioma Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance Imaging, Radiation Therapy - Glioma | Phase 1 | Recruiting | Susan Chang | 140 | 2015-12-09 | 2026-06-18 |
| Everolimus in Treating Patients With Recurrent Low-Grade Glioma Everolimus, Archival Tissue Analysis - Adult Diffuse Astrocytoma, Adult Mixed Glioma | Phase 2 | Completed | Susan Chang | 58 | 2009-01-23 | 2020-07-28 |
Glioma (4) · Astrocytoma (1) · Brain Neoplasms (1) · Glioblastoma (1) · Oligodendroglioma (1)
Magnetic Resonance Spectroscopy (3) · Drug Therapy (1) · Everolimus (1) · Radiation (1) · Radiotherapy (1)
United States (5)
P50CA097257 (3), R01CA109767 (1), R01CA262630 (1), R01CA273028 (1)